SCHEMBL23619059

SCHEMBL23619059

CC(C)[C@H](N)[C@H](O)c1cc(F)cc(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
KDM4E B2RXH2 5/20 0.37
RECQL P46063 4/20 0.37
TDP1 Q9NUW8 4/20 0.37
MAPT P10636 3/20 0.37
LMNA P02545 3/20 0.37
HIF1A Q16665 2/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
THPO P40225 1/20 0.37
HSD17B10 Q99714 1/20 0.37
POLB P06746 1/20 0.37
APEX1 P27695 1/20 0.37
MTOR P42345 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37
ADRB1 P08588 1/20 0.36
MIF P14174 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15934390 0.83 KDM4E (0.50) CES2CES1KDM4ERECQLTDP1
SCHEMBL10582769 0.77 ADRA1A (0.50) KDM4ERECQLTDP1MAPTLMNA
SCHEMBL30620670 0.76 CES2 (0.42) CES2CES1CYP3A4CYP2D6SLC6A2
SCHEMBL23622257 0.73 KDM4E (0.51) CES2CES1KDM4ETDP1ALOX15
SCHEMBL16169013 0.73 IDO1 (0.35) CES2CES1HTR2ACA12CA1
SCHEMBL557913 0.72 IDO1 (0.42) CES2CES1CA12CA1CA9
SCHEMBL1004099 0.72 IDO1 (0.42) CES2CES1CA12CA1CA9
SCHEMBL1728961 0.72 IDO1 (0.42) CES2CES1CA12CA1CA9
SCHEMBL1154665 0.72 CES2 (0.46) CES2CES1KMT2ACYP3A4CYP2D6
SCHEMBL4094087 0.72 CES2 (0.46) CES2CES1KMT2ACYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167068-A1 BENZOPYRAZOLE COMPOUND MEDSHINE DISCOVERY INC. (CN) 2023-06-01 US disclosed
WO-2021136429-A1 BENZOPYRAZOLE COMPOUND 南京明德新药研发有限公司 2021-07-08 WO disclosed
WO-2021136431-A1 BENZO[D][1,2,3]TRIAZOLE ETHER COMPOUND 南京明德新药研发有限公司 2021-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167068-A1 BENZOPYRAZOLE COMPOUND ABCB1, CYP3A43, CYP3A5 CES2 377/4885CES1 1404/4885KDM4E 3643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.